The market size of the global flexible endoscope will be estimated at USD 12.7 billion in 2025 and is expected to grow between USD 13.5 billion in 2026 and about USD 22.7 billion by 2035 with a current CAGR of 6.0% during the period of 2026 to 2035.
Flexible Endoscope Market Revenue and Trends
A flexible endoscope is a medical instrument that performs a visual inspection, diagnoses, and treats the conditions occupying the internal organs, and cavities of the body in a non-intrusive way or through small openings. It consists of an insertion tube that is long, thin, and flexible at the same time, and that contains a light source, a high-resolution camera or a fiber-optic imaging system, and one or more working channels through which the instruments can pass for biopsy, suction, irrigation, or therapeutic procedures. Flexible endoscopes' ability to bend and navigate through complex anatomical pathways makes them perfect for examining the different parts of the body such as the gastrointestinal tract, respiratory system, urinary tract, and other delicate structures. They are involved with many procedures including gastroscopy, colonoscopy, bronchoscopy, and cystoscopy and are central to the whole process of minimally invasive diagnostics and treatment that depends on real-time visualization with fair patient comfort level, quicker recovery, and lower risk compared to traditional surgical techniques. The market growth is driven by several factor such as increasing prevalence of cancer, growing product launch and increasing investment in emerging market by the key market players.
What are the Factors That Have a Significant Contribution to the Growth of the Flexible Endoscope market?
The flexible endoscopes market is experiencing significant growth due to an amalgamation of various factors like clinical, technological, economic, and regulatory which in turn are increasing the number of procedures and speeding up the adoption of equipment across the different healthcare sectors.
The global burden of diseases affecting the gastrointestinal and respiratory systems which are very painful and expensive to treat as they include conditions like GERD, colorectal cancer, inflammatory bowel disease, COPD, and lung infections is also one of the main factors which is driving the endoscope market. Controlling and monitoring the diseases through endoscopic means requires frequent diagnosis and monitoring. Besides this, the industry is also turning to the less challenging method of open surgeries, i.e. flexible endoscopy, to do less harm to the patients, cut hospital stays, and treatment costs.
Aside from this, medical science is making great leaps technologically and that is also a major factor driving the endoscope market. Along with the introduction of high-definition and 4K imaging, and enhanced visualization techniques, the AI-powered lesion detection and advanced tissue imaging (optical biopsy) practices are there to add to diagnostic accuracy and to build the clinical confidence that hospitals will be more likely to upgrade or to get rid of their old systems. More focus on infection control and patient safety has also led to faster adoption of single-use flexible endoscopes and endoscopes with disposable parts, thus creating new revenue streams and penetrating high-risk procedures more.
Segment Insight
By Product
The gynecology endoscopes segment is growing at a significant rate over the projected period. The increasing incidence of various gynecological disorders, including but not limited to uterine fibroids, endometriosis, polycystic ovary syndrome (PCOS), and cancers of the cervix and uterus, is the main reason for the growth of this market. Patients suffering from such diseases invariably require the diagnostic and therapeutic endoscopic interventions of the highest order. As the awareness around women’s health issues gets bigger and the screening and early intervention programs grow, mere reliance on flexible endoscopes for procedures translates into a great volume of procedures and, consequently, sales of the related equipment.
Regional Insights
The flexible endoscope market has been dominated by North America. The North America region has also been supported by advanced healthcare infrastructure, government initiatives that are conducive to healthcare and optimum treatment coverage.
Besides, the Asia Pacific market has the highest rate of growth in the flexible endoscope market. The major influencing factor for this upsurge is the heavy burden of the target illnesses, and the expectation of a significant patient group is also going to help the growth of the area. The healthcare infrastructure in the region is getting better and more money is being invested by the market players, mostly because of the booming demand for medical devices in the APAC region, and thus the region has been growing to a certain degree.
Report Scope
Feature of the Report | Details |
Market Size in 2026 | USD 13.5 billion |
Projected Market Size in 2035 | USD 22.7 billion |
Market Size in 2025 | USD 12.7 billion |
CAGR Growth Rate | 6% CAGR |
Base Year | 2025 |
Forecast Period | 2026-2035 |
Key Segment | By Product, End Use and Region |
Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Recent Developments
In August 2024, KARL STORZ United States, an international pioneer in Operating Room (OR) integration, has partnered with FUJIFILM Healthcare Americas Corporation (Fujifilm), a prominent manufacturer of endoscopic imaging and endosurgical products, to supply a wide array of solutions for both endoscopists and surgeons. The two companies will together promote Fujifilm’s exceptional flexible gastrointestinal (GI) endoscopes and KARL STORZ’s unmatched OR integration solutions. The partnership between Fujifilm and KARL STORZ will support the upgrading of surgical ORs, routine and interventional hospital GI suites, and ambulatory surgery centers (ASCs) with the benefits of innovative OR integration and state-of-the-art flexible endoscopes in areas where most GI and surgical OR procedures are done. (Source: https://www.biopharmaapac.com/news/77/5181/karl-storz-and-fujifilm-healthcare-partner-to-enhance-gi-endoscopy-and-or-integration.html)
List of the prominent players in the Flexible Endoscope Market:
Olympus Corporation
Cook Medical Inc.
Becton Dickinson and Company
Boston Scientific Corporation
Cantel Medical Corporation
Conmed Corporation
B. Braun SE
EndoMed Systems GmbH
Firefly Global
Fujifilm Holdings Corporation
H.W.Andersen Products Ltd.
Hoya Corporation
Intuitive Surgical Inc.
Karl Storz SE & Co. KG
Machida Endoscope Co. Ltd
Ambu A/S
Others
The Flexible Endoscope Market is segmented as follows:
By Product
Bronchoscopes
Laparoscopes
Otoscopes
Laryngoscopes
Cystoscopes
Ureteroscopes
Arthroscopes
Nasopharyngoscopes
Neuroendoscopes
Rhinoscopes
Gastrointestinal Endoscopes
Hysteroscopes
Gynecology Endoscopes
By End Use
Hospitals
Outpatient Facilities
Regional Coverage:
North America
U.S.
Canada
Mexico
Rest of North America
Europe
Germany
France
U.K.
Russia
Italy
Spain
Netherlands
Rest of Europe
Asia Pacific
China
Japan
India
New Zealand
Australia
South Korea
Taiwan
Rest of Asia Pacific
The Middle East & Africa
Saudi Arabia
UAE
Egypt
Kuwait
South Africa
Rest of the Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
